Prospective study on the role of cytidine deaminase activity in lung cancer patients treated with gemcitabine-platinum-based chemotherapy

Winter Meeting of the EORTC-PAMM 2018, Roma, Italy, 7-10 February 2018

Oral presentation by Dr. Carmelo Tibaldi: Prospective study on the role of cytidine deaminase activity in lung cancer patients treated with gemcitabine-platinum-based chemotherapy.
Tibaldi C, Camerini A, Tiseo M,  Mazzoni F, Barbieri F, Vittimberga I, Brighenti M, Boni L, Baldini E, Honeywell R, Chartoire M,  Peters GJ, Giovannetti E.

The results of this study have been published in British Journal of Cancer:
www.ncbi.nlm.nih.gov/pubmed/30405211

Moreover we wrote a commentary on CDA activity in British Journal of Clinical Pharmacology:
www.bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13921

PDF file: Prospective study on the role of cytidine deaminase activity